vimarsana.com
Home
Live Updates
Dermavant Sciences: Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in JAAD : comparemela.com
Dermavant Sciences: Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in JAAD
- ADORING 1 and ADORING 2 met their primary efficacy endpoints and all secondary endpoints - - ADORING 1 and ADORING 2 data were included in the sNDA filing for VTAMA cream, 1% in atopic dermatitis
Related Keywords
United States ,
American ,
Eli Lilly ,
Angela Salerno Robin ,
Philipm Brown ,
Twitter ,
Linkedin Dermavant Sciences ,
Roivant Sciences ,
Dermavant Sciences Gmb ,
Journal Of The American Academy Dermatology ,
Dermavant Sciences Inc ,
Dermavant Sciences ,
American Academy ,
Chief Medical Officer ,
Secondary Endpoints ,
Prescribing Information ,
All Rights ,
Vice President ,
Media Relations ,
Ihr Portfolio ,
comparemela.com © 2020. All Rights Reserved.